Sam Fazeli

$SMMT @adamfeuerstein FDA Approval: MARIPOSA2, Amivantamab plus Chemotherapy after Osimertinib for EGFR NSCLC by Lung Cancer Considered via #soundcloud https://t.co/JbBByYWbji

IO meets Alzheimer’s. May be there is something that those TIM-3 antibodies could do here in combination with anti-amyloid antibodies. Immune checkpoint TIM-3 regulates microglia and Alzheimer’s disease | Nature https://t.co/xOGHYilupa

I had a great conversation with Houman Ashrafian, head of R&D at $SAN. I wish it was just after the $VIGL acquisition but sadly it was a week or so before. https://t.co/bdrtFtpxd7

$MRNA $PFE $BNTX $NVAX $TRSBF $SMMT $JNJ $GMAB $URGN $AMGN $SNY $VIGL $MRUS $MRK $BCAX $ZTS $IONS $BHC Listen to DC Update, Biopharma 1Q Ownership, ASCO Preview: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud https://t.co/hjVbdPrHJg

RT @BiotechCH: On today’s #BiotechHangout, @SamFazeli8, @JMaraganore, @nkjellson, and @gline discuss MFN (Most Favored Nation): the 30-day…

$GILD $VRTX $AZN $REGN $BMY $GK $1348180D $BIIB $ESAIY $LLY $NVO $ZTS $IDXX $ELAN Listen to US Drug Pricing, Alzheimer’s Survey, Pet Economy: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud https://t.co/zIktP9pzRR

Nice balanced conversation - as always excellent https://t.co/tYWBvx3WjQ

It’s not always a great idea to give cash back. Apple history: Michael Dell says he'd shut down Apple https://t.co/8oLzOzJad2

Sorry - late again. $BNTX $BMY $MRK $PFE $AMGN $JNJ $ABBV $NVS $AZN $GSK $SNY $NVO $BIIB $ESAIY $LLY $RVMD $REGN Listen to US Drug Prices; Patent Cliffs; Alzheimer’s Survey: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud https://t.co/gh0sMlMTV0

Nice to see the DFS impact - but is it enough to have no detrimental impact on OS? Imfinzi …. statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC https://t.co/gDIIKKuB29

I had not realised that, according to them, $NVO did not seek exclusivity with $CVS for Wegovy - suggesting they did not negotiate on price - as I had assumed.